Subscribe to RSS
DOI: 10.1055/s-0038-1657203
A Possible Method to Control Prolongations of Bleeding Time under Antiplatelet Therapy with Ticlopidine
Publication History
Received 05 March 1982
Accepted 03 May 1982
Publication Date:
13 July 2018 (online)
Summary
The interactions of oral and i.v. administrations of corticosteroids with the effects of ticlopidine were studied, in a search for an antidote for possible excessive prolongations of bleeding time induced by antiaggregating agents. Indeed, the results show that an i.v. injection of methylprednisolone or an oral treatment with prednisolone counteract the prolongation of bleeding time but do not interfere with the inhibition of platelet aggregation brought about by ticlopidine. This could be ascribed to a vasoconstrictive effect of corticosteroids, possibly through reduction of vascular prostacyclin release. If this mode of action was confirmed, this useful finding would essentially apply to ticlopidine, but not to cyclooxygenase inhibitors such as aspirin which, by themselves, abolish prostacyclin production.
-
References
- 1 Thébault JJ, Blatrix CE, Blanchard JF, Panak EA. Effects of ticlopidine, a new platelet aggregation inhibitor in man. Clin Pharmacol Ther 1975; 18: 485-490
- 2 Lecrubier C, Conard J, Samama M, Bousser MG. Essai randomisé d’un nouvel agent antiagrégant: la ticlopidine. Thérapie 1977; 32: 189-194
- 3 Bom GVR, Cross MJ. The aggregation of blood platelets. J Physiol (Lond) 1963; 168: 178-195
- 4 Ivy AC, Nelson D, Bucher G. The standardization of certain factors in the cutaneous venostasis bleeding time technique. J Lab Clin Med 1941; 26: 1812-1822
- 5 Favre-Gilly J, Thouverez JP, Belleville J, Revol L, Croizat P. Les allongements isolés du temps de saignement. Nouv Rev Fr Hematol 1963; 3: 350-355
- 6 Caen J, Parquet-Gemez A. Corticothérapie dans les allongements du temps de saignement. Nouv Rev Fr Hematol 1963; 3: 355-361
- 7 Gryglewski RJ, Panczenko B, Korbut R, Grodzinska A, Oczekiewicz A. Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea-pig. Prostaglandins 1975; 10: 343-355
- 8 Flower RJ, Blackwell GJ. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 1979; 278: 456-459
- 9 Jorgensen KA, Stoffersen E. Hydrocortisone inhibits platelet prostaglandin and endothelial prostacyclin production. Pharmacol Res Commun 1981; 13: 579-586
- 10 Glass F, Lippton H, Kadowitz PJ. Effects of methylprednisolone and hydrocortisone on aggregation of rabbit platelets induced by arachidonic acid and other aggregating substances. Thromb Haemostas 1981; 46: 676-679
- 11 Ellis DJ, Roe RL, Bruno JJ, Cranston BJ, Mc Spadden MM. The effects of ticlopidine hydrochloride on bleeding time and platelet function in man. Thromb Haemostas 1981; 46: 176 (Abstr.)
- 12 David JL, Monfort F, Herion F, Raskinet R. Compared effects on three dose-levels of ticlopidine on platelet function in normal subjects. Thromb Res 1979; 14: 35-49
- 13 Mielke Jr CH, Levine PH, Zucker S. Preoperative Prednisone therapy in platelet function disorders. Thromb Res 1981; 21: 655-662